Clinical Trial Update: A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2, single-arm clinical trial evaluating pembrolizumab with gemcitabine and cisplatin as perioperative therapy for potentially resectable intrahepatic ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• KEYTRUDA (PEMBROLIZUMAB)
• Platinol (cisplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cholangiocarcinoma | Phase 2 | Status: RECRUITING